Literature DB >> 10817495

Biological markers: maintaining standards. Biomarkers Ad-hoc Group of the United Kingdom Coordinating Committee on Cancer Research.

.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10817495      PMCID: PMC2374511          DOI: 10.1054/bjoc.2000.1158

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

Review 1.  Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.

Authors:  D M Barnes; R R Millis; L V Beex; S M Thorpe; R E Leake
Journal:  Eur J Cancer       Date:  1998-10       Impact factor: 9.162

2.  Improved prognosis for biomarkers in breast cancer.

Authors:  M Dowsett
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

3.  Oestrogen receptors and breast cancer.

Authors:  R M Elledge; C K Osborne
Journal:  BMJ       Date:  1997-06-28

Review 4.  Oestrogen receptors and breast cancer: current status.

Authors:  R A Hawkins; M M Roberts; A P Forrest
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

Review 5.  Serological markers of cancer and their applications in clinical trials.

Authors:  K J Helzlsouer
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

6.  Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.

Authors:  S Romain; C Lainé Bidron; P M Martin; H Magdelenat
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

7.  External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts.

Authors:  C G Sweep; J Geurts-Moespot; N Grebenschikov; J H de Witte; J J Heuvel; M Schmitt; M J Duffy; F Jänicke; M D Kramer; J A Foekens; N Brünner; G Brugal; A N Pedersen; T J Benraad
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.